Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.02 USD | +7.86% | +30.74% | +67.78% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 33.33M | Capitalization | 74.94M |
---|---|---|---|---|---|
Net income 2024 * | -47M | Net income 2025 * | -33M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.25 x |
P/E ratio 2024 * |
-2.68
x | P/E ratio 2025 * |
-4.84
x | Employees | 20 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.5% |
Latest transcript on Eledon Pharmaceuticals, Inc.
1 day | +7.86% | ||
1 week | +30.74% | ||
Current month | +26.36% | ||
1 month | +92.36% | ||
3 months | +65.03% | ||
6 months | +137.80% | ||
Current year | +67.78% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 20-04-30 | |
Paul Little
DFI | Director of Finance/CFO | 60 | 21-03-14 |
Steven Perrin
PSD | President | 59 | 20-09-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Keith Katkin
CHM | Chairman | 52 | 17-04-30 |
Walter Ogier
BRD | Director/Board Member | 67 | 20-09-13 |
John McBride
BRD | Director/Board Member | 72 | 17-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 3.02 | +7.86% | 611,409 |
24-05-16 | 2.8 | +11.78% | 572,048 |
24-05-15 | 2.505 | +7.05% | 143,937 |
24-05-14 | 2.34 | +6.85% | 135,948 |
24-05-13 | 2.19 | -5.19% | 237,726 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.78% | 74.94M | |
+9.42% | 115B | |
+11.84% | 106B | |
-14.15% | 21.84B | |
-1.05% | 21.96B | |
-5.29% | 19.21B | |
-38.29% | 17.71B | |
-4.16% | 18.08B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- ELDN Stock